Harapan Kita Hospital, Jakarta, Indonesia Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2002
NCT00529490
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

National cardiac Centre, Harapan Kita Hospital, Dept. of Anaesthesiology, Intensive Care Unit, Jakarta, Indonesia | National Cardiovascular Centre Harapan Kita Jakarta Indonesia

Active Ingredients

Drugs in Phase 4 Trials (1)

thiamine (1 trial)

Drugs in Phase 3 Trials (2)

lactic acid (1 trial)

ringer's lactate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Beriberi (Phase 4)

Cardiac Output, Low (Phase 3)

Heart Defects, Congenital (Phase 4)

Heart Diseases (Phase 4)

Thiamine Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3